Showing 88 of 88on this page. Filters & sort apply to loaded results; URL updates for sharing.88 of 88 on this page
DailyMed - AUGTYRO- repotrectinib capsule
Repotrectinib 40mg capsule at ₹ 44300/box | Anti Cancer Medicines in ...
Repotrectinib 40 mg Capsule at ₹ 44280/bottle | Pharmaceutical Capsules ...
40mg Augtyro Repotrectinib Capsules at ₹ 52500/box in Ahmedabad | ID ...
Repotrectinib 40mg, 60 Capsule at best price in Surat | ID: 2855392855048
Augtyeo Repotrectinib Capsules at ₹ 140000/box | Antineoplastic Agent ...
Repotrex 40 mg | Generic Repotrectinib by Everest Pharmaceuticals
LuciRepo ( Repotrectinib 40mg ) hộp 60 viên - Điều trị ung thư Phổi ...
Repotrectinib in ROS1 Fusion–Positive Lung Cancer | New England Journal ...
Repotrectinib (Augtyro) 2025 Updates: Uses in Cancer, Side effects ...
Repotrectinib Capsules – Pharmasolution
Repotrectinib Uses, Side Effects & Warnings
Repotrectinib NTRK | Non-small Cell Lung Cancer | HK DengYue
EP08.02-011 Design of a Phase I Trial (TOTEM) to Test Repotrectinib in ...
Molecular Characteristics of Repotrectinib That Enable Potent ...
Repotrectinib (TPX-0005) | ALK inhibitor | CAS 1802220-02-5 | Selleck
RxTROSPECT — FDA approves repotrectinib for ROS1-positive non-small ...
Figure 1 from Molecular Characteristics of Repotrectinib That Enable ...
Repotrectinib | 1802220-02-5 | CXC22002 | Biosynth
Thuốc Repotrectinib điều trị ung thư phổi tế bào nhỏ dương tính ROS1
Repotrectinib Overcomes F2004V Resistance Mutation in ROS1-Rearranged ...
Repotrectinib in ROS1 Fusion–Positive Non–Small-Cell Lung Cancer | NEJM
Repotrectinib – Application in Therapy and Current Clinical Research
Repotrectinib (瑞普替尼) – 美仑生物
Repotrectinib Powder - NDC 10745-1332
OA03.06 Repotrectinib in Patients with ROS1 Fusion-positive (ROS1 ...
美国NTRK 融合癌症特效药 Repotrectinib获FDA加速批准
产品中心
Maximizing the Benefits of LuciRepo (Repotrectinib): A Comprehensive ...
FDA Approves Augtyro (repotrectinib) for the Treatment of Locally ...
Repodx (repotrectinib) | NextGen
REPODX(Repotrectinib)瑞普替尼 | 百配健康-阅读越健康!
瑞普替尼胶囊40mg*60粒/盒 奥凯乐 ALIREPOTINIB Repotrectinib_肺癌_肿瘤药品_印度直邮购-印度药房直邮商城 ...
【瑞普替尼,洛普替尼,奥凯乐,repotrectinib,AUGTYRO,TPX-0005,ALIREPOTINIB】说明书_代购价格_印度 ...
瑞普替尼Repotrectinib治疗ROS1阳性肺癌的真实世界颅内疗效与耐受性-CSDN博客
瑞波替尼(AUGTYRO/REPOTRECTINIB)在ROS1阳性NSCLC患者中表现出了优异的抗肿瘤活性【康必行海外医疗】
REPODX (Repotrectinib) - Big Bear Pharmaceutical Co., Ltd.
Repotrex 40 MG (Repotrectinib) Capsules | Onco Solution
瑞普替尼/洛普替尼_Repotrex_40 mg*56粒_主要成分为Repotrectinib_印度/老挝/孟加拉专业跨境医疗咨询与用药安全 ...
Repotrex (Repotrectinib 40mg) Rx - elifesavingmedicine
Medicine | JK Medicine | Oncology Medicine Services
Repotrex 40 Mg (Repotrectinib) Capsules - Worldwide Delivery
Resiliva 80 Mg (Resmetirom) Rx | Orio Pharma
从靶向药“新贵”瑞普替尼（Repotrectinib）看小分子大环化 - 知乎
Repodx (Repotrectinib 40mg) Rx - elifesavingmedicine
瑞普替尼（Repotrectinib）治疗ROS1阳性晚期NSCLC全球首仿在老挝获批上市！ - 知乎
Luci-Repo 40mg, (Repotrectinib) at ₹ 27840/box | DABHOLI ROAD. | Surat ...
Repotrectinib: a promising new therapy for advanced nonsmall cell lung ...
Repoitin Injection - Repoitin 4000 Latest Price, Manufacturers & Suppliers
Slide 9
AUGTYRO™ (repotrectinib) - New FDA Approved ROS1+ Non-Small Cell Lung ...
LuciRepo (Repotrectinib 40mg) Rx - elifesavingmedicine
FDA加速批准瑞普替尼Repotrectinib(Augtyro)用于NTRK基因融合阳性实体瘤 - 香港致泰药业
Augtyro (repotrectinib) Capsules - Dosage Form: 125mg at Best Price in ...
Augtyro(repotrectinib，瑞普替尼)2025年最新进展：抗癌用途、副作用、剂量、预期疗效等-上市-医保-临床适应症-香港济民药业
瑞普替尼（Repotrectinib）的治疗效果怎么样【海得康海外医疗】
【瑞普替尼,洛普替尼,奥凯乐,repotrectinib,TPX-0005,Augtyro（美版）】说明书_代购价格_印度直邮-印度全球药房
OncoApteka | Доступ к современной таргетной онкотерапии и ...
【瑞波替尼说明书】_洛普替尼_瑞普替尼_Augtyro_Repotrectinib-【康必行海外医疗】
Augtyro (repotrectinib) dosing, indications, interactions, adverse ...
Thuốc LuciRepo 40mg (Repotrectinib) - Điều Trị Ung Thư
Augtyro(repotrectinib,瑞普替尼)_土耳其登越药业有限公司官网_登越药业专注药品进口抗癌药、靶向药、新特药、仿制药、罕见病药品等。
Effectiveness and cost-effectiveness of first-line versus second-line ...
Green Synthesis of Repotrectinib: Impact of Aqueous Micellar Media on ...
Repotrectinib: Why Did BMS Pay $4.1 Billion for Turning Point ...
Repotrex (repotrectinib) | NextGen
瑞普替尼(Repotrectinib)奥凯乐,Augtyro,洛普替尼-40mg*60粒/盒-老挝卢修斯制药
AUGTYRO (Repotrectinib) for the Treatment of ROS1-Positive Non-Small ...
Trk Receptor | Trk受体 | 抑制剂 | MCE
祝贺！百时美施贵宝repotrectinib获FDA批准 百时美施贵宝 （Bristol Myers Squibb）宣布，美国FDA批准其口服 ...
近八成患者肿瘤大幅缩小或消失，美国肺癌前沿药Repotrectinib公布临床试验新进展-出国看病-盛诺一家
Repoitin 10000 IU Injection at ₹ 490/piece in Surat | ID: 2858244711630
Slide 8
Augtyro Repotrectinib: What Patients Really Want To Know?
Repotrectinib（瑞普替尼）治疗ROS1阳性晚期NSCLC最新研究数据公布 - 知乎
再鼎医药新一代广谱抗癌药Repotrectinib获CDE优先审评 - 知乎
Augtyro (repotrectinib) | NextGen
Slide 7
7+ Hundred Tyrosine Kinase Inhibitors Royalty-Free Images, Stock Photos ...
AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion ...
.png)
